N9 World Technologies, India has signed an agreement with Consolidated Pathways Inc., USA to incorporate unique Swiss antiviral and antimicrobial technologies into sustainable, cost-effective custom blends for the textile industry.
N9’s special offerings provide antiviral performance against the Coronavirus bringing proven hygiene function and material protection to the textile industry which will be available in Bangladesh for its textile industry.This partnership will now allow both companies to offer unique performance benefit platforms to the global textile industry, said a press release.
This new antiviral technology will be marketed under the umbrella brand ‘VIROBAN’ and is very effective against the enveloped and capsid viruses.
It is proven to reduce infective viruses by 99.99 percent when tested under ISO 18184, and the polymers are designed to have high compatibility with textiles and be safe on human skin.
VIROBAN N9 XTS-18 creates a highly-cationic charge density on the textile surface, deactivating the spread of the virus and bacteria on contact.
The technology is designed to act quickly to prevent the transmission of the virus. Any antiviral claims are subject to regulation in countries where such regulations exist and N9 assists its customers in assuring that such regulations are strictly adhered to.
Vikram Rao, Managing Director of N9 World Technologies said with the onslaught of the pandemic, consumers are increasingly seeking protection and safety in almost everything they breathe, touch or wear.“With this partnership, N9 World Technologies is now a ‘One Stop Shop’ for global brands and retailers who are seeking innovative and sustainable specialty finish for their textile products,” said Vikram Rao.